Dr. Jean B Belasco M.D.

Expert Publications

• Primary follicular lymphoma of the testis in childhood.
• Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children.
• Supportive care: palliative care in children, adolescents, and young adults--model of care, interventions, and cost of care: a retrospective review.
• Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1.
• Variation in receipt of opioids by pediatric oncology patients who died in
• Pulmonary metastases and bone sarcomas. Surgical removal of lesions appearing after adjuvant chemotherapy.
• Intermittent low-dose central nervous system radiation for high-risk pediatric leukemia patients: preliminary results.
• A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
• Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
• Primary atypical optic nerve sheath meningioma in a child with restricted diffusion on magnetic resonance imaging.
• Premature Epiphyseal Closure of the Lower Extremities Contributing to Short Stature after cis-Retinoic Acid Therapy in Medulloblastoma: A Case Report.
• Acute promyelocytic leukemia presenting as a pelvic mass.
• Acute promyelocytic leukemia presenting as a pelvic mass.
• Occult neuroblastoma: difficulties of diagnosis.
• Occult neuroblastoma: difficulties of diagnosis.

Media Releases

Get to know Pediatric Hematologist/Oncologist Dr. Jean Bello Belasco, who serves patients in Philadelphia, Pennsylvania.

A devoted pediatrician, Dr. Belasco is an attending physician in the Cancer Center at Children’s Hospital of Philadelphia. Her areas of special interest include pediatric brain and spine tumors, neurofibromatosis, supportive care, and vascular and lymphatic malformations.

Children’s Hospital of Philadelphia (CHOP) is the nation’s first hospital devoted exclusively to the care of children. Since their start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic firsts in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives.

With a broad educational background, Dr. Belasco graduated with her medical degree from the Temple University School of Medicine, and completed her internship and residency in pediatrics at St. Christopher’s Hospital for Children. She then went on to complete her fellowship in hematology/oncology at the University of North Carolina, Chapel Hill, and her fellowship in pediatric oncology at the Children’s Hospital of Philadelphia.

Subsequent to her education, the doctor attained board certification in pediatric hematology/oncology and pediatrics through the American Board of Pediatrics (ABP). The mission of the ABP is to advance child health by certifying pediatricians who meet standards of excellence and are committed to continuous learning and improvement.

In good standing with a number of professional organizations, Dr. Belasco is an active member of the Academy of Hospice and Palliative Medicine, the Neurofibromatosis Consortium, the American Society of Clinical Oncology, and the American Academy of Pediatrics.

Active in academia, she serves as a Professor of Clinical Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.

An avid researcher, Dr. Belasco’s neuro-oncology brain tumors, neurofibromatosis and related tumors, and investigational therapies for refractory brain tumors and for progressive, severe plexiform neurofibromas.

Pediatric oncology is a medical specialty focused on the care of children with cancer. A pediatric hematologist/oncologist is a physician who has special training and experience to diagnose and treat blood disorders and cancers in children, teens, and young adults.

As a testament to her success, Dr. Belasco has been the recipient of the Patients’ Choice Award (2018, 2017, 2016, 2014, 2011, 2009), Compassionate Doctor Recognition (2018, 2017, 2014, 2011), Alex’s Pitcher of Hope Award (2010), Master Clinician Award (2007), Temple University Gallery of Success Award (2007), Children’s Hospital of Philadelphia Faculty Honor Roll (2003-2004), Supportive Care Services ACCH Award for Innovation (1996), and Pharmacology Award (1973).

Recommended Articles

• An Overview of Vaccinations

  There are different vaccines actively used in practical medicine, specifically by pediatricians. Artificial immunization is the greatest achievement of modern microbiological technologies. It has already saved millions of lives all around the world. The production of vaccines is a sophisticated...

• Treatments For Genital Herpes

  Even though there is no cure for genital herpes, several treatments are available. Treatment of genital herpes is aimed at relieving symptoms and reducing the frequency of recurrent infections (outbursts). Most cases of herpes may be resolved without treatment. However, treatment is important as it...

• Purpura

  PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...

• Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients

  Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...

• How Is Leukemia Diagnosed?

  Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...

• Potential Causes of Leukopenia

  IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...